VSM Wealth Advisory’s Amgen AMGN Stock Holding History

VSM Wealth Advisory’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109K	Hold	300	–	–	0.03%	154
2026 Q1	$106K	Hold	300	–	–	0.03%	150
2025 Q4	$98.2K	Hold	300	–	–	0.03%	143
2025 Q3	$84.7K	Hold	300	–	–	0.03%	149
2025 Q2	$83.8K	Hold	300	–	–	0.03%	157
2025 Q1	$93.5K	Hold	300	–	–	0.03%	135
2024 Q4	$78.2K	Buy	+300	New	+$89K	0.03%	151

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

VSM Wealth Advisory's AMGN Position: Q2 2026 in Review

VSM Wealth Advisory held its Amgen (AMGN) position steady in Q2 2026 at 300 shares worth $109K. The position accounts for 0.03% of the portfolio, ranked #154.

VSM Wealth Advisory first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

VSM Wealth Advisory held 300 shares of Amgen worth $109K as of Q2 2026.
VSM Wealth Advisory left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.03% of VSM Wealth Advisory's portfolio in Q2 2026, its #154 holding.
VSM Wealth Advisory first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.